SAB Biotherapeutics (SABS) - Earnings growth in current year
SAB Biotherapeutics is implementing software robots and automated screening to accelerate drug development. The annual percentage growth in net income per share illustrates the yield dynamics, where -36.40 represents the current level of the metric. Success is based on a proprietary polyclonal antibody platform, which guarantees monopoly income, and a team of leading immunologists working under exceptional conditions.
Financial and market metric breakdowns for SAB Biotherapeutics (SABS)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Total Debt to Capital Coefficient SAB Biotherapeutics|SABS - Long-Term Debt to Capital|Short-Term Debt to Capital sabbiotherapeutics.com|SABS - Company Aggregate Debts|Debt to Book Capitalization Ratio SAB Biotherapeutics Inc|SABS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings SAB Biotherapeutics|Quick Liquidity sabbiotherapeutics.com
- earnings and market ratios statistics:
SABS - Net Profit|Company Profit Forecast SAB Biotherapeutics|SABS - Price to Earnings Ratio|Projected Price to Earnings Ratio SAB Biotherapeutics Inc|SABS - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio SAB Biotherapeutics Inc|SABS - Operating profit EBITDA|Earnings per share for the trailing year SAB Biotherapeutics|SABS - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months sabbiotherapeutics.com|SABS - Earnings per share growth in current year|Expected earnings per share trend next year SAB Biotherapeutics
- sales volume and revenue information:
Fundamental valuation:SAB Biotherapeutics Inc., SABS
This indicator determines the year-over-year dynamics of net income per share. By analyzing the comparable growth rate of earnings per share over the year, an investor assesses the efficiency of capital generation. The metric is calculated as the percentage deviation of the current EPS from the value of the same period last year. A positive trend confirms business scaling. For SAB Biotherapeutics (SABS), this reflects the commercial return from licensing the DiversitAb platform in alliances with pharma behemoths.
Key competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|GRFS - Earnings per share growth in current year|Expected net earnings per share growth this year Adaptive Biotechnologies Inc. ADPT|CLDX: Earnings growth in current year|auriniapharma.com (AUPH) - Earnings growth in current year|BCRX (BioCryst Pharmaceuticals) - Earnings growth in current year|Earnings per share growth in current year VERA|Net earnings per share growth this year DNTH (Dianthus Pharma)|PHVS (Pharvaris Pharma) - Earnings per share increase in current year|Earnings growth in current year ABCL (AbCellera Biologics)|tourmalinebio.com - Earnings per share growth in current year|Precigen - Earnings growth in current year|Expected net earnings per share growth this year Pharming Group NV PHAR|Nektar (NKTR) - Earnings per share growth in current year|Earnings per share growth rate in current year Upstream Pharma (UPB)|Net earnings per share growth this year ZBIO|IMNM (immunome.com) - Net earnings per one share growth for the current year|Earnings growth in current year GOSS|KALV (KalVista Pharma) - Earnings per share increase in current year|Earnings growth in current year SEPN (Septerna Corp)|Pieris Corp (PVLA) - Earnings per share growth rate in current year|SVRA - Earnings per share growth in current year|Earnings per share increase in current year RIGL (rigel.com)|ANAB: Earnings growth in current year|Astria Therapeutics Inc (ATXS) - Earnings growth in current year|Earnings per share growth in current year enGene Bio|RAPT Therapeutics Inc. - Earnings per share trend in current year|Earnings growth in current year JBIO|ACRS - Earnings per share growth rate in current year|Kyverna Therapeutics, Inc. - Net earnings per share growth this year|Earnings growth in current year Tiziana Life Sciences Ltd. TLSA|CABA: Net earnings per share growth this year|Ventyx Biosciences, Inc - Net earnings per one share growth for the current year|THTX: Earnings growth in current year|AVTX - Expected net earnings per share growth this year|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth in current year|Net earnings per share growth this year Agenus, Inc. (AGEN)|Earnings per share growth in current year Climb Bio, Inc. (CLYM)|Expected net earnings per share growth this year Zura Bio Ltd|Earnings per share growth in current year aTyr Pharma, Inc. ATYR|Expected net earnings per share growth this year Adagene Inc (ADAG)|Ikena Oncology, Inc. - Earnings growth in current year|STTK - Earnings growth in current year|EQ: Earnings growth in current year|CNTB (Connect Biopharma Holdings Limited) - Earnings per share growth in current year|Earnings per share growth in current year Immunic Therapeutics|Atara Biotherapeutics Inc (ATRA) - Expected net earnings per share growth this year|Earnings per share growth in current year InflaRx N.V. (IFRX)|XFOR: Earnings per share trend in current year|Earnings growth in current year ACET (Adicet Bio, Inc.)|Earnings per share increase in current year CELU|INmune Bio, Inc. - Earnings growth in current year|BRNS - Earnings growth in current year|Kezar Life Sciences, Inc. (KZR) - Earnings per share growth in current year|Akari Therapeutics PLC - Earnings per share increase in current year|Earnings per share growth in current year Enlivex Therapeutics Ltd|Net earnings per share growth this year Q32 Bio Corp (QTTB)|Earnings growth in current year GOVX|Earnings growth in current year edesabiotech.com (EDSA)|iBio - Net earnings per share growth this year|Earnings per share increase in current year CARM|XTL Biopharmaceuticals, Ltd. - Earnings growth in current year|Expected net earnings per share growth this year Bolt Biotherapeutics BOLT|hcwbiologics.com (HCWB) - Earnings per share growth in current year|Net earnings per share growth this year Aptevo Therapeutics Inc.|Earnings per share growth in current year AIM ImmunoTech Inc.|Net earnings per share growth this year Aditxt Corp (ADTX)|Net earnings per share growth this year GRI (GRI Bio Corp)|Earnings growth in current year XORTX Corp (XRTX)|Earnings per share growth in current year Vyome Holdings Inc HIND|REVB: Earnings per share growth this year|Indaptus Therapeutics, Inc. - Earnings growth in current year|Earnings per share growth rate in current year Scinai Immunotherapeutics Ltd|calcimedica.com (CALI) - Earnings per share growth in current year|AFMD - Expected net earnings per share growth this year|ALLK (Allakos Inc) - Earnings growth in current year|Earnings growth in current year HOOKIPA|Earnings growth in current year IGMS|Earnings per share growth in current year ITOS (iTeos Therapeutics Inc)|Ocean Bio - Net earnings per share growth this year|Earnings per share increase in current year TCBP|Third Harmonic Bio - Earnings growth in current year
